174 related articles for article (PubMed ID: 31721179)
21. A novel MFSD8 mutation in a Russian patient with neuronal ceroid lipofuscinosis type 7: a case report.
Kozina AA; Okuneva EG; Baryshnikova NV; Krasnenko AY; Tsukanov KY; Klimchuk OI; Kondakova OB; Larionova AN; Batysheva TT; Surkova EI; Shatalov PA; Ilinsky VV
BMC Med Genet; 2018 Aug; 19(1):151. PubMed ID: 30144815
[TBL] [Abstract][Full Text] [Related]
22. [Clinical characteristics and genetic analysis of a case with adult neuronal ceroid lipofuscinosis type 7 due to variant of MFSD8 gene].
He S; Chen S; Peng Y; Fan X; Li S; Zhang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Apr; 40(4):395-401. PubMed ID: 36972931
[TBL] [Abstract][Full Text] [Related]
23. A major facilitator superfamily domain 8 frameshift variant in a cat with suspected neuronal ceroid lipofuscinosis.
Guevar J; Hug P; Giebels F; Durand A; Jagannathan V; Leeb T
J Vet Intern Med; 2020 Jan; 34(1):289-293. PubMed ID: 31860737
[TBL] [Abstract][Full Text] [Related]
24. Clinico-pathological manifestations of variant late infantile neuronal ceroid lipofuscinosis (vLINCL) caused by a novel mutation in MFSD8 gene.
Mandel H; Cohen Katsanelson K; Khayat M; Chervinsky I; Vladovski E; Iancu TC; Indelman M; Horovitz Y; Sprecher E; Shalev SA; Spiegel R
Eur J Med Genet; 2014; 57(11-12):607-12. PubMed ID: 25270050
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a CLN7 model of Batten disease in non-human primates.
McBride JL; Neuringer M; Ferguson B; Kohama SG; Tagge IJ; Zweig RC; Renner LM; McGill TJ; Stoddard J; Peterson S; Su W; Sherman LS; Domire JS; Ducore RM; Colgin LM; Lewis AD
Neurobiol Dis; 2018 Nov; 119():65-78. PubMed ID: 30048804
[TBL] [Abstract][Full Text] [Related]
26. Case Report: Novel MFSD8 Variants in a Chinese Family With Neuronal Ceroid Lipofuscinoses 7.
Qiao Y; Gu Y; Cheng Y; Su Y; Lv N; Shang Q; Xing Q
Front Genet; 2022; 13():807515. PubMed ID: 35154277
[TBL] [Abstract][Full Text] [Related]
27. Expression and lysosomal targeting of CLN7, a major facilitator superfamily transporter associated with variant late-infantile neuronal ceroid lipofuscinosis.
Sharifi A; Kousi M; Sagné C; Bellenchi GC; Morel L; Darmon M; Hulková H; Ruivo R; Debacker C; El Mestikawy S; Elleder M; Lehesjoki AE; Jalanko A; Gasnier B; Kyttälä A
Hum Mol Genet; 2010 Nov; 19(22):4497-514. PubMed ID: 20826447
[TBL] [Abstract][Full Text] [Related]
28. Retinal Phenotype of Patients With Isolated Retinal Degeneration Due to CLN3 Pathogenic Variants in a French Retinitis Pigmentosa Cohort.
Smirnov VM; Nassisi M; Solis Hernandez C; Méjécase C; El Shamieh S; Condroyer C; Antonio A; Meunier I; Andrieu C; Defoort-Dhellemmes S; Mohand-Said S; Sahel JA; Audo I; Zeitz C
JAMA Ophthalmol; 2021 Mar; 139(3):278-291. PubMed ID: 33507216
[TBL] [Abstract][Full Text] [Related]
29. A novel pathogenic frameshift variant unmasked by a large de novo deletion at 13q21.33-q31.1 in a Chinese patient with neuronal ceroid lipofuscinosis type 5.
Li W; Fan X; Zhang Y; Huang L; Jiang T; Qin Z; Su J; Luo J; Yi S; Zhang S; Shen Y
BMC Med Genet; 2020 May; 21(1):100. PubMed ID: 32393339
[TBL] [Abstract][Full Text] [Related]
30. The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function.
Parvin S; Rezazadeh M; Hosseinzadeh H; Moradi M; Shiva S; Gharesouran J
Neuromolecular Med; 2019 Jun; 21(2):160-169. PubMed ID: 30919163
[TBL] [Abstract][Full Text] [Related]
31. Exome sequencing is an efficient tool for variant late-infantile neuronal ceroid lipofuscinosis molecular diagnosis.
Patiño LC; Battu R; Ortega-Recalde O; Nallathambi J; Anandula VR; Renukaradhya U; Laissue P
PLoS One; 2014; 9(10):e109576. PubMed ID: 25333361
[TBL] [Abstract][Full Text] [Related]
32. The Chihuahua dog: A new animal model for neuronal ceroid lipofuscinosis CLN7 disease?
Faller KM; Bras J; Sharpe SJ; Anderson GW; Darwent L; Kun-Rodrigues C; Alroy J; Penderis J; Mole SE; Gutierrez-Quintana R; Guerreiro RJ
J Neurosci Res; 2016 Apr; 94(4):339-47. PubMed ID: 26762174
[TBL] [Abstract][Full Text] [Related]
33. A novel CLN8 mutation in late-infantile-onset neuronal ceroid lipofuscinosis (LINCL) reveals aspects of CLN8 neurobiological function.
Vantaggiato C; Redaelli F; Falcone S; Perrotta C; Tonelli A; Bondioni S; Morbin M; Riva D; Saletti V; Bonaglia MC; Giorda R; Bresolin N; Clementi E; Bassi MT
Hum Mutat; 2009 Jul; 30(7):1104-16. PubMed ID: 19431184
[TBL] [Abstract][Full Text] [Related]
34. Clinical and genetic characterization of neuronal ceroid lipofuscinoses (NCLs) in 29 Iranian patients: identification of 11 novel mutations.
Panjeshahi S; Karimzadeh P; Movafagh A; Ahmadabadi F; Rahimian E; Alijanpour S; Miryounesi M
Hum Genet; 2023 Aug; 142(8):1001-1016. PubMed ID: 37074398
[TBL] [Abstract][Full Text] [Related]
35. AAV9/MFSD8 gene therapy is effective in preclinical models of neuronal ceroid lipofuscinosis type 7 disease.
Chen X; Dong T; Hu Y; Shaffo FC; Belur NR; Mazzulli JR; Gray SJ
J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35025759
[TBL] [Abstract][Full Text] [Related]
36. Novel
Priluck AZ; Breazzano MP
Ophthalmic Genet; 2023 Apr; 44(2):186-190. PubMed ID: 35801630
[TBL] [Abstract][Full Text] [Related]
37. Neuronal ceroid lipofuscinosis in the Russian population: Two novel mutations and the prevalence of heterozygous carriers.
Kozina AA; Okuneva EG; Baryshnikova NV; Kondakova OB; Nikolaeva EA; Fedoniuk ID; Mikhailova SV; Krasnenko AY; Stetsenko IF; Plotnikov NA; Klimchuk OI; Popov YV; Surkova EI; Shatalov PA; Rakitko AS; Ilinsky VV
Mol Genet Genomic Med; 2020 Jul; 8(7):e1228. PubMed ID: 32412666
[TBL] [Abstract][Full Text] [Related]
38. Novel likely disease-causing CLN5 variants identified in Pakistani patients with neuronal ceroid lipofuscinosis.
Azad B; Efthymiou S; Sultan T; Scala M; Alvi JR; Neuray C; Dominik N; ; Gul A; Houlden H
J Neurol Sci; 2020 Jul; 414():116826. PubMed ID: 32302805
[TBL] [Abstract][Full Text] [Related]
39. Novel mutations in CLN6 cause late-infantile neuronal ceroid lipofuscinosis without visual impairment in two unrelated patients.
Chin JJ; Behnam B; Davids M; Sharma P; Zein WM; Wang C; Chepa-Lotrea X; Gallantine WB; Toro C; Adams DR; Tifft CJ; Gahl WA; Malicdan MCV
Mol Genet Metab; 2019 Feb; 126(2):188-195. PubMed ID: 30528883
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
